SANA Metropolitan Hotel, Lisbon, Portugal | 11 July 2025Institutions involved: GIMM, UPF, Synovo The 9th Periodic Working Meeting took place in Lisbon and brought together all consortium partners for an integrated discussion of the results obtained, coordination of institutional contributions, and preparation of final reports and dissemination activities.

RCSI, Dublin, Ireland | 25–27 August 2025 Members of the project participated in the 12th International Meeting on Antimicrobial Peptides (IMAP), where they presented and discussed the results of the NOVIRUSES2BRAIN project with the international research community. This meeting served as an important platform for scientific dissemination, knowledge exchange on peptide-based therapeutic strategies, and the …
Continue reading 12th International Meeting on Antimicrobial Peptides (IMAP)

On 10–11 July 2025, the NOVIRUSES2BRAIN project successfully organised the NOVIRUSES2BRAIN Symposium 2025: Ahead of Future Pandemics at the SANA Metropolitan Hotel, in Lisbon, Portugal. This 1.5-day international symposium brought together leading experts and early-career researchers working in virology, preclinical development, and translational medicine, creating a multidisciplinary forum to address current and future challenges in …
Continue reading NOVIRUSES2BRAIN Symposium 2025: Ahead of Future Pandemics

On May 15th, 2025, 15-year-old students (9th grade) from Colégio Sagrado Coração de Maria in Lisbon participated in a special session of the United Nations Junior Model Meeting, focused on Goal 3: Health and Well-being. Miguel Castanho led the event, which featured the inspiring question, “If you were a scientist, what would you change in …
Continue reading United Nations Junior Model Meeting: Goal 3 – Health and Well-being with Miguel Castanho at Colégio Sagrado Coração de Maria

At the Gulbenkian Institute of Molecular Medicine, scientific research has advanced based on lessons learned during the COVID-19 pandemic. In Miguel Castanho’s lab, researchers continue working on developing a drug with potential activity against multiple viruses, reinforcing the commitment to innovation and global health.Learn more: https://www.rtp.pt/noticias/pais/ciencia-depois-da-covid-19-igmm-investiga-farmaco-contra-multiplos-virus_

On March 19th, 2025, Miguel Castanho was a guest on the Antena 1 podcast Consulta Pública, in the episode titled “COVID-19: What Have We Learned?”. During the discussion, he shared insights and reflections on the key lessons from the pandemic, highlighting scientific advances and future challenges for public health.

On February 21st, 2025, Miguel Castanho took part in a special session at the Gustavo Pinto Lopes Municipal Library titled “If You Were a Biochemist, What Would You Change in the World?”. The event, aimed at middle and high school students as well as the general public, featured the presentation of the NOVIRUSES2BRAIN project, which …
Continue reading “If You Were a Biochemist, What Would You Change in the World?” — Miguel Castanho at Gustavo Pinto Lopes Municipal Library

On February 11th, 2025, Miguel Castanho participated in the 7th Annual Meeting of the Master’s Program in Biochemistry and Biomedicine at the Faculty of Sciences of the University of Lisbon, which gathered around 100 students. During the event, he presented the NOVIRUSES2BRAIN project, focused on developing innovative therapies against brain-targeting viruses. A great opportunity to …
Continue reading Miguel Castanho presents NOVIRUSES2BRAIN project to Biochemistry and Biomedicine students at FCUL

On the International Day of Women and Girls in Science, we celebrate the women at MCastanho Lab who drive research forward every day.

Miguel Castanho, a researcher at the Institute of Molecular Medicine, explains that a mixture of flu strains is currently circulating in Portugal, with influenza B being predominant. According to the expert, this combination causes milder to moderate symptoms and has less potential to cause pandemics, which clarifies the current flu situation in the country.